Werewolf Therapeutics is a clinical-stage company advancing cancer immunotherapy utilizing a conditionally activated cytokine PREDATOR™ system.
Arkin Entry Stage
Early
Status
IPO
Location
Boston, MA
Let’s get in touch!
